Journal of Bacteriology, April 2001, p. 2380-2383, Vol. 183, No. 7
0021-9193/01/$04.00+0   DOI: 10.1128/JB.183.7.2380-2383.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

FosB, a Cysteine-Dependent Fosfomycin Resistance Protein under the Control of ^W, an Extracytoplasmic-Function  Factor in Bacillus subtilis

Department of Microbiology, Cornell University, Ithaca, New York 14853-8101,¹ and Department of Biochemistry and the Center in Molecular Toxicology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146²

Received 5 October 2000/Accepted 27 December 2000

	ABSTRACT

Top Abstract Text References

We demonstrate that the Bacillus subtilis fosB(yndN) gene encodes a fosfomycin resistance protein. Expression of fosB requires ^W, and both fosB and sigW mutants are fosfomycin sensitive. FosB is a metallothiol transferase related to the FosA class of Mn²⁺-dependent glutathione transferases but with a preference for Mg²⁺ and L-cysteine as cofactors.

	TEXT

Top Abstract Text References

Sequencing of the Bacillus subtilis genome revealed the presence of seven new  factors, all members of the extracytoplasmic function subfamily (12, 13). We have begun to investigate their functions by mutation of each gene and the identification of target operons (8-11). In this work, we demonstrate that yndN encodes a fosfomycin resistance (Fos^r) protein that depends on ^W for expression. We have renamed yndN as fosB, based on its similarity to the fosB gene identified on a Staphylococcus epidermidis plasmid (Fig. 1B).

View larger version (24K): [in this window] [in a new window]   FIG. 1.   The fosB(yndN) gene encodes a fosfomycin resistance protein. (A) The fosB(yndN) region of the chromosome is illustrated. The fosB gene is transcribed from a W-dependent promoter similar in sequence to the sigW autoregulatory promoter, Pw (9). (B) Multiple sequence alignment of the 144-amino-acid B. subtilis FosB protein (Bsu) with FosB from S. epidermidis (63% identity [21]) and with FosA from Tn2921 (33% identity [14]). Residues identical in all three protein sequences are shown in bold, and those residues identical between the more closely related FosB homologs are underlined in the B. subtilis sequence.

Transcription of fosB requires ^W. Previously, 15 ^W-dependent operons were identified by searching the genome for sequences matching the ^W autoregulatory site, P_w: TGAAAC N₁₆ CGTA (10). Additional candidate promoters, including one for fosB (Fig. 1A), were identified with 17-bp spacer regions (10).

To confirm the role of this predicted ^W-dependent promoter, we generated a P_fosB-cat-lacZ operon fusion inserted ectopically in the SP prophage (HB8083; Table 1) and transduced the reporter fusion into wild-type, sigW, and rsiW mutant backgrounds. Promoter activity as determined in early-stationary-phase cells yielded 18.4 Miller units of -galactosidase in the wild-type strain (HB0052), and this was reduced to background levels (~1 unit) in the sigW mutant (HB0023). In the rsiW (anti-^W) mutant (HB0012), expression was elevated approximately twofold (30.5 units). This pattern is precisely that expected for a ^W-dependent promoter.

View this table: [in this window] [in a new window]   TABLE 1.   B. subtilis strains, plasmids, and oligonucleotides used in this study

We used reverse transcriptase primer extension mapping to identify the transcriptional start site for fosB as a G residue 10 bases downstream from the 10 region CGTA motif (Fig. 2). There were no other start sites visible in the primer extension experiment, which is consistent with the idea that ^W is largely, if not exclusively, responsible for fosB transcription. The fosB gene is apparently monocistronic, as it is flanked on either side by genes transcribed from the complementary strand of the genome (Fig. 1A).

View larger version (77K): [in this window] [in a new window]   FIG. 2.   Expression of fosB depends on W. Primer extension analysis of the fosB transcription start site is shown. RNA was isolated from logarithmically growing cells in Luria-Bertani medium of strains CU1065 (wild type), HB0020 (sigW mutant), and HB0010 (rsiW mutant). Equal amounts (100 µg) of total RNA were annealed with radiolabeled oligonucleotide no. 370 prior to analysis by reverse transcriptase primer extension. The transcription start site is the G residue shown in bold. G,A,T, and C are the sequencing ladder obtained with the same primer.

fosB and sigW mutants are sensitive to fosfomycin. Both fosB (HB0008) and sigW (HB0020) mutants are fosfomycin sensitive: an MIC of 50 µg/ml for the mutants compared to 800 µg/ml for the wild type in liquid culture. Similarly, the sigW and fosB mutants have a much greater zone of growth inhibition in disk diffusion assays (~25-mm zone for wild type versus >50 mm for the mutants). The fosB and sigW mutant strains did not display altered sensitivity to several other antibiotics, including vancomycin, cephalosporin C, penicillin G, D-cycloserine, tunicamycin, nisin, and bacitracin. Induction of fosB from a xylose-inducible promoter completely restores Fos^r to either the sigW mutant (HB0081) or, as expected, to the fosB mutant (HB0082). Thus, fosB is the only ^W-dependent gene required for wild-type levels of Fos^r.

Expression of FosB confers fosfomycin resistance to Escherichia coli. For mechanistic studies, we overproduced FosB in E. coli. Transformation of E. coli BL21/DE3(pLysS) with pMC50 leads to high fosfomycin resistance, even under noninducing conditions (MIC > 20 mg/ml, as judged using commercial antibiotic disks [Becton Dickinson, Cockeysville, Md.]). This is comparable to the Fos^r imparted by a similar FosA overexpression plasmid (MIC > 30 mg/ml). This suggests that an appropriate thiol cofactor for FosB is present in E. coli. To compare the relative efficacy of FosA and FosB in protecting E. coli against fosfomycin, the MIC determinations were repeated using plates containing 20 mM glucose-6-phosphate (an inducer of fosfomycin uptake). Under these conditions, FosA still supported high-level fosfomycin resistance (MIC, >30 mg/ml), while resistance of the strain expressing FosB was dramatically reduced (MIC, ~1.25 mg/ml). This difference may relate to the lower catalytic efficiency of FosB compared to FosA (see below).

FosB: an Mg²⁺-dependent cysteine thiol transferase. FosB was purified using modifications of the FosA procedure (3). Gel filtration chromatography indicated that FosB is a dimer in either the presence or absence of divalent metal ions. The metal ion selectivity of FosB was examined and found to be Ni²⁺ ~ Mg²⁺ > Mn²⁺ > Fe²⁺ > Cu²⁺ > Ca²⁺ ~ Co²⁺ > Zn²⁺ when screened with a fixed (0.5 mM) concentration of metal. Activation was almost 10-fold greater with Ni²⁺ and Mg²⁺ (Fig. 3) than with Mn²⁺. Although Ni²⁺ activates the enzyme at lower concentrations, the activation constant for Mg²⁺ (200 µM) is well below the prevailing Mg²⁺ concentration of about 1 mM. Therefore, we suggest that Mg²⁺ is the physiologically relevant metal. In contrast to FosA (2), FosB does not require a monovalent cation for optimal activity.

View larger version (13K): [in this window] [in a new window]   FIG. 3.   Activation of FosB with Ni2+ and Mg2+ using L-cysteine as the thiol substrate. The experimental data for Ni2+ () and Mg2+ () were fit to the quadratic form of a simple binding isotherm to obtain the activation constant for the metal (KactM) and the maximum rate constant (kmaxM) for activation under the conditions of the assay. The solid lines are fits of the experimental data for the two metals, with KactNi = 9 ± 3 µM, kmaxNi = 1.0 ± 0.1 s1, KactMg = 180 ± 30 µM, and kmaxMg = 0.75 ± 0.04 s1. For comparison, the results for Mn2+ under the same conditions were KactMn = 3.5 ± 0.9 µM and kmaxMn = 0.11 ± 0.01 s1.

FosA functions as a glutathione transferase (3). Since B. subtilis, like many gram-positive bacteria, lacks detectable levels of glutathione (5, 15), it seems likely that FosB must use a different thiol. To identify the FosB thiol cofactor, the rate of appearance of conjugates of fosfomycin with various thiols was determined as described previously (3, 4). L-Cysteine and coenzyme A sulfhydryl (CoASH) are two abundant thiols in gram-positive bacteria (5, 15). Of the two, only L-cysteine supports a modest enzyme activity (Table 2). The product of the FosB-catalyzed addition of L-cysteine to fosfomycin, examined by heteronuclear multiple-bond correlation nuclear magnetic resonance spectroscopy, is (1R,2S)-1-(S-L-cysteinyl)-2-hydroxypropylphosphonate (data not shown), identical to the product produced by FosA with L-cysteine (4). Extended incubations of FosB, fosfomycin, and various divalent metal ions indicated that no degradation of the antibiotic occurred in the absence of a thiol substrate.

View this table: [in this window] [in a new window]   TABLE 2.   Steady-state kinetic parameters of the thiol substrate and metal-ion selectivity of FosB

Although with glutathione the catalytic efficiency of FosB is significantly less than that of FosA (k_cat/K_m = [1.7 ± 0.3] × 10⁵ M¹ s¹), they are about equally active with L-cysteine (k_cat/K_m = 410 ± 40 M¹ s¹). These rate constants are still at least 10⁶ to 10⁸ greater than those reported for the spontaneous reactions (2). The optimal catalytic efficiency of FosB (with L-cysteine) is far lower than FosA efficiency (with glutathione), which may reflect an intrinsic difference in catalytic efficiency or could indicate that a physiologically relevant cofactor for FosB has not yet been identified. To verify that L-cysteine is the thiol donor in vivo, it will be necessary to characterize the product of fosfomycin inactivation from intact cells.

Summary. Fosfomycin is a clinically important, broad-spectrum antibiotic that irreversibly inactivates MurA, which catalyzes the first committed step in peptidoglycan biosynthesis (17). Resistance arises predominantly via mutations in the chromosomally encoded transport pathways (7) or by resistance genes found on transmissible plasmids. At least two classes of plasmid-borne Fos^r determinants have been described (reviewed in reference 19). The best characterized, fosA, encodes a Mn²⁺-dependent glutathione transferase (1-3). A related resistance gene, fosB, is from an S. epidermidis plasmid. FosB is 38% identical to FosA, suggesting a similar mechanism of action (21), as confirmed in this study. Indeed, the plasmid-borne fosA resistance determinants may have arisen from chromosomal genes, like fosB, that serve a defensive role within soil microorganisms such as B. subtilis.

There are several significant mechanistic differences between FosA and FosB. FosB, unlike FosA, does not function efficiently with glutathione and instead appears to use L-cysteine as the physiological thiol donor. Analyses of S. epidermidis FosB have also indicated that glutathione is not involved in detoxification (R. Asano and J. Davies, personal communication). A second mechanistic difference is that FosB uses Mg²⁺ rather than Mn²⁺ as metal cofactor. The final notable difference between FosA and FosB is catalytic efficiency. FosA exhibits a very high catalytic efficiency (k_cat/K_m), perhaps in response to selection pressures imposed by the clinical use of fosfomycin.

The assignment of fosB to the ^W regulon further validates the "consensus search" approach for defining alternative  factor regulons (9-11), and it supports the emerging picture of ^W as a regulator of a broad, "antibiosis" regulon involved in both the production of, and defense against, antimicrobial compounds.

	ACKNOWLEDGMENTS

We thank Xuejun Huang, Ahmed Gaballa, and Kurt Fredrick for construction of plasmids and strains used in this work and T. Msadek for providing plasmid pXT.

This work was supported by grants from the National Institutes of Health to J.D.H. (GM47446) and R.N.A. (AI42756).

	FOOTNOTES

^* Corresponding author. Mailing address: Department of Microbiology, Cornell University, Ithaca, NY 14853-8101. Phone: (607) 255-6570. Fax: (607) 255-3904. E-mail: jdh9{at}cornell.edu.

	REFERENCES

Top Abstract Text References

1.	Arca, P., C. Hardisson, and J. E. Suarez. 1990. Purification of a glutathione S-transferase that mediates fosfomycin resistance in bacteria. Antimicrob. Agents Chemother. 34:844-848[Abstract/Free Full Text].
2.	Bernat, B. A., L. T. Laughlin, and R. N. Armstrong. 1999. Elucidation of a monovalent cation dependence and characterization of the divalent cation binding site of the fosfomycin resistance protein (FosA). Biochemistry 38:7462-7469[CrossRef][Medline].
3.	Bernat, B. A., L. T. Laughlin, and R. N. Armstrong. 1997. Fosfomycin resistance protein (FosA) is a manganese metalloglutathione transferase related to glyoxalase I and the extradiol dioxygenases. Biochemistry 36:3050-3055[CrossRef][Medline].
4.	Bernat, B. A., L. T. Laughlin, and R. N. Armstrong. 1998. Regiochemical and stereochemical course of the reaction catalyzed by the fosfomycin resistance protein, FosA. J. Org. Chem. 6:3778-3780[CrossRef].
5.	Fahey, R. C., W. C. Brown, W. B. Adams, and M. B. Worsham. 1978. Occurrence of glutathione in bacteria. J. Bacteriol. 133:1126-1129[Abstract/Free Full Text].
6.	Guérout-Fleury, A.-M., K. Shazand, N. Frandsen, and P. Stragier. 1995. Antibiotic-resistance cassettes for Bacillus subtilis. Gene 167:335-336[CrossRef][Medline].
7.	Horii, T., T. Kimura, K. Sato, K. Shibayama, and M. Ohta. 1999. Emergence of fosfomycin-resistant isolates of Shiga-like toxin-producing Escherichia coli O26. Antimicrob. Agents Chemother. 43:789-793[Abstract/Free Full Text].
8.	Huang, X., A. Decatur, A. Sorokin, and J. D. Helmann. 1997. The Bacillus subtilis X protein is an extracytoplasmic function sigma factor contributing to the survival of high temperature stress. J. Bacteriol. 179:2915-2921[Abstract/Free Full Text].
9.	Huang, X., K. L. Fredrick, and J. D. Helmann. 1998. Promoter recognition by Bacillus subtilis W: autoregulation and partial overlap with the X regulon. J. Bacteriol. 180:3765-3770[Abstract/Free Full Text].
10.	Huang, X., A. Gaballa, M. Cao, and J. D. Helmann. 1999. Identification of target promoters for the Bacillus subtilis extracytoplasmic function  factor, W. Mol. Microbiol. 31:361-371[CrossRef][Medline].
11.	Huang, X., and J. D. Helmann. 1998. Identification of target promoters for the Bacillus subtilis X factor using a consensus-directed search. J. Mol. Biol. 279:165-173[CrossRef][Medline].
12.	Lonetto, M. A., K. L. Brown, K. E. Rudd, and M. J. Buttner. 1994. Analysis of the Streptomyces coelicolor sigE gene reveals the existence of a subfamily of eubacterial  factors involved in the regulation of extracytoplasmic functions. Proc. Natl. Acad. Sci. USA 91:7573-7577[Abstract/Free Full Text].
13.	Missiakas, D., and S. Raina. 1998. The extracytoplasmic function sigma factors: role and regulation. Mol. Microbiol. 28:1059-1066[CrossRef][Medline].
14.	Navas, J., J. Leon, M. Arroyo, and J. M. Garcia Lobo. 1990. Nucleotide sequence and intracellular location of the product of the fosfomycin resistance gene from transposon Tn2921. Antimicrob. Agents Chemother. 34:2016-2018[Abstract/Free Full Text].
15.	Newton, G. L., K. Arnold, M. S. Price, C. Sherrill, S. B. Delcardayre, Y. Aharonowitz, G. Cohen, J. Davies, R. C. Fahey, and C. Davis. 1996. Distribution of thiols in microorganisms: mycothiol is a major thiol in most actinomycetes. J. Bacteriol. 178:1990-1995[Abstract/Free Full Text].
16.	Perego, M. 1993. Integrational vectors for genetic manipulation in Bacillus subtilis, p. 615-624. In A. L. Sonenshein, J. A. Hoch, and R. Losick (ed.), Bacillus subtilis and other gram-positive bacteria: biochemistry, physiology, and molecular genetics. American Society for Microbiology, Washington, D.C.
17.	Skarzynski, T., A. Mistry, A. Wonacott, S. E. Hutchinson, V. A. Kelly, and K. Duncan. 1996. Structure of UDP-N-acetylglucosamine enolpyruvyl transferase, an enzyme essential for the synthesis of bacterial peptidoglycan, complexed with substrate UDP-N-acetylglucosamine and the drug fosfomycin. Structure 4:1465-1474[Medline].
18.	Slack, F. J., J. P. Mueller, and A. L. Sonenshein. 1993. Mutations that relieve nutritional repression of the Bacillus subtilis dipeptide permease operon. J. Bacteriol. 175:4605-4614[Abstract/Free Full Text].
19.	Suarez, J. E., and M. C. Mendoza. 1991. Plasmid-encoded fosfomycin resistance. Antimicrob. Agents Chemother. 35:791-795[Free Full Text].
20.	Youngman, P. 1990. Use of transposons and integrational vectors for mutagenesis and construction of gene fusions in Bacillus species, p. 221-266. In C. R. Harwood, and S. M. Cutting (ed.), Molecular biological methods for Bacillus. John Wiley and Sons, Ltd., Chichester, United Kingdom.
21.	Zilhao, R., and P. Courvalin. 1990. Nucleotide sequence of the fosB gene conferring fosfomycin resistance in Staphylococcus epidermidis. FEMS Microbiol. Lett. 56:267-272[Medline].
22.	Zuber, P., and R. Losick. 1987. Role of AbrB and SpoOA- and SpoOB-dependent utilization of a sporulation promoter in Bacillus subtilis. J. Bacteriol. 169:2223-2230[Abstract/Free Full Text].